|
Pronunciation |
|
(klor
fen IR a meen, fen il tole LOKS
a meen, fen il proe pa NOLE a meen & fen il EF
rin) |
|
|
U.S. Brand
Names |
|
Naldecon®; Naldelate®;
Nalgest®; Nalspan®; New Decongestant®; Par
Decon®; Tri-Phen-Chlor®; Uni-Decon® |
|
|
Generic
Available |
|
Yes |
|
|
Pharmacological Index |
|
Antihistamine/Decongestant Combination |
|
|
Use |
|
Symptomatic treatment of nasal and eustachian tube congestion associated with
sinusitis and acute upper respiratory infection; symptomatic relief of perennial
and allergic rhinitis |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Usual Dosage |
|
Oral:
3-6 months: 1/4
mL (pediatric drops) every 3-4 hours
6-12 months: 2.5 mL (pediatric syrup) or
1/2
mL (pediatric drops) every 3-4 hours
1-6 years: 5 mL (pediatric syrup) or 1 mL (pediatric drops) every 3-4 hours
6-12 years: 2.5 mL (syrup) or 10 mL (pediatric syrup) or
1/2
tablet every 3-4 hours
Children >12 years and Adults: 5 mL (syrup) or 1 tablet every 3-4 hours
|
|
|
Dietary
Considerations |
|
May be administered with food or water |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
Use with caution since phenylpropanolamine & phenylephrine are
sympathomimetic amines which could interact with epinephrine to cause a pressor
response |
|
|
Dental Health:
Effects on Dental Treatment |
|
Chlorpheniramine: Prolonged use will cause significant xerostomia
Phenylephrine, Phenylpropanolamine: Up to 10% of patients could experience
tachycardia, palpitations, and dry mouth; use vasoconstrictor with caution
|
|
|
Patient
Information |
|
May cause drowsiness. Alcohol may worsen this effect. Use caution when
driving or operating machinery. |
|
|
Dosage Forms |
|
Drops, pediatric: Chlorpheniramine maleate 0.5 mg, phenyltoloxamine citrate 2
mg, phenylpropanolamine hydrochloride 5 mg, and phenylephrine hydrochloride 1.25
mg per mL
Syrup: Chlorpheniramine maleate 2.5 mg, phenyltoloxamine citrate 7.5 mg,
phenylpropanolamine hydrochloride 20 mg, and phenylephrine hydrochloride 5 mg
per 5 mL
Syrup, pediatric: Chlorpheniramine maleate 0.5 mg, phenyltoloxamine citrate 2
mg, phenylpropanolamine hydrochloride 5 mg, and phenylephrine hydrochloride 1.25
mg per 5 mL
Tablet, sustained release: Chlorpheniramine maleate 5 mg, phenyltoloxamine
citrate 15 mg, phenylpropanolamine hydrochloride 40 mg, and phenylephrine
hydrochloride 10 mg |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|